France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> The COVID Pandemic As “X-Ray” – Zeroing In On Urban Water & Sanitation Gaps 22/03/2021 Madeleine Hoecklin COVID has highlighted deep-seated weaknesses in urban water and sanitation systems that are vital to health – but the pandemic has also underlined how improvements can hit back at the SARS-CoV2 virus – as well as reducing other traditional waterborne diseases. That was a key message at a seminar Monday on “Water and Sanitation in […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Repeat COVID-19 Infections Are Rare, But People Over 65 Are At Greater Risk of Catching COVID Again – Lancet Study 18/03/2021 Madeleine Hoecklin Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet. In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> The COVID Pandemic As “X-Ray” – Zeroing In On Urban Water & Sanitation Gaps 22/03/2021 Madeleine Hoecklin COVID has highlighted deep-seated weaknesses in urban water and sanitation systems that are vital to health – but the pandemic has also underlined how improvements can hit back at the SARS-CoV2 virus – as well as reducing other traditional waterborne diseases. That was a key message at a seminar Monday on “Water and Sanitation in […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Repeat COVID-19 Infections Are Rare, But People Over 65 Are At Greater Risk of Catching COVID Again – Lancet Study 18/03/2021 Madeleine Hoecklin Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet. In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> The COVID Pandemic As “X-Ray” – Zeroing In On Urban Water & Sanitation Gaps 22/03/2021 Madeleine Hoecklin COVID has highlighted deep-seated weaknesses in urban water and sanitation systems that are vital to health – but the pandemic has also underlined how improvements can hit back at the SARS-CoV2 virus – as well as reducing other traditional waterborne diseases. That was a key message at a seminar Monday on “Water and Sanitation in […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Repeat COVID-19 Infections Are Rare, But People Over 65 Are At Greater Risk of Catching COVID Again – Lancet Study 18/03/2021 Madeleine Hoecklin Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet. In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The COVID Pandemic As “X-Ray” – Zeroing In On Urban Water & Sanitation Gaps 22/03/2021 Madeleine Hoecklin COVID has highlighted deep-seated weaknesses in urban water and sanitation systems that are vital to health – but the pandemic has also underlined how improvements can hit back at the SARS-CoV2 virus – as well as reducing other traditional waterborne diseases. That was a key message at a seminar Monday on “Water and Sanitation in […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Repeat COVID-19 Infections Are Rare, But People Over 65 Are At Greater Risk of Catching COVID Again – Lancet Study 18/03/2021 Madeleine Hoecklin Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet. In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Repeat COVID-19 Infections Are Rare, But People Over 65 Are At Greater Risk of Catching COVID Again – Lancet Study 18/03/2021 Madeleine Hoecklin Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet. In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Repeat COVID-19 Infections Are Rare, But People Over 65 Are At Greater Risk of Catching COVID Again – Lancet Study 18/03/2021 Madeleine Hoecklin Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet. In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Repeat COVID-19 Infections Are Rare, But People Over 65 Are At Greater Risk of Catching COVID Again – Lancet Study 18/03/2021 Madeleine Hoecklin Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet. In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Union Proposes A Travel Certificate System, While Region Pushes Back Against UK Over Vaccine Exports 18/03/2021 Madeleine Hoecklin The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer. The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts